prikaz prve stranice dokumenta Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
Pristup korisnicima matične ustanove
Znanstveni rad - Pismo
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
Leukemia Research, 119 (2022); 106905. https://doi.org/10.1016/j.leukres.2022.106905
Lucijanić, Marko; Krečak, Ivan; Soric, Ena; Sabljić, Anica; Galusic, Davor; Holik, Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Kušec, Rajko

Citirajte ovaj rad

Lucijanić, M., Krečak, I., Soric, E., Sabljić, A., Galusic, D., Holik, H. ... Kušec, R. (2022). Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. Leukemia Research, 119.. doi: 10.1016/j.leukres.2022.106905

Lucijanić, Marko, et al. "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis." Leukemia Research, vol. 119, 2022. https://doi.org/10.1016/j.leukres.2022.106905

Lucijanić, Marko, Ivan Krečak, Ena Soric, Anica Sabljić, Davor Galusic, Hrvoje Holik, Vlatka Periša, Martina Morić Perić, Ivan Zekanović i Rajko Kušec. "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis." Leukemia Research 119 (2022). https://doi.org/10.1016/j.leukres.2022.106905

Lucijanić, M., et al. (2022) 'Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis', Leukemia Research, 119. doi: 10.1016/j.leukres.2022.106905

Lucijanić M, Krečak I, Soric E, Sabljić A, Galusic D, Holik H, i sur.. Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. Leukemia Research [Internet]. 08.2022. [pristupljeno 03.12.2024.];119. doi: 10.1016/j.leukres.2022.106905

M. Lucijanić, et al., "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis", Leukemia Research, vol. 119, Kolovoz 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:839295. [Citirano: 03.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:839295
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
AutorMarko Lucijanić
AutorIvan Krečak
AutorEna Soric
AutorAnica Sabljić
AutorDavor Galusic
AutorHrvoje Holik
AutorVlatka Periša
AutorMartina Morić Perić
AutorIvan Zekanović
AutorRajko Kušec
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pismo
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaLeukemia Research
Brojčani podacivol. 119, 106905
p-ISSN0145-2126
DOIhttps://doi.org/10.1016/j.leukres.2022.106905
URN:NBNurn:nbn:hr:184:839295
Datum objave publikacije2022-08
URL dokumentahttps://linkinghub.elsevier.com/retrieve/pii/S014521262200131X
Vrsta resursaTekst
Prava pristupaInstitucijski pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-11-14 10:54:56